QIAGEN N.V.: Release of a capital market information

DGAP Post-admission Duties announcement: QIAGEN N.V. / Share Buyback QIAGEN N.V.: Release of a capital market information 11.09.2018 / 13:41 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 in conjunction with Article 2 Section (2) and (3) of the Delegated EU Regulation 2016/1052 / Share Repurchase - Interim Reporting With disclosure dated September 05, 2018, QIAGEN N.V. announced pursuant to Article 5 Section (1) and (6) of the EU Regulation no 596/2014 and Article 2 Section (1) of the Delegated EU Regulation no 2016/1052 the immediate beginning of a second tranche of up to USD 50 million under the share repurchase program originally announced on January 31, 2018. The number of shares which have been bought back on the electronic trading platform of the Frankfurt Stock Exchange (XETRA) within the framework of such tranche of the share repurchase program in the time period from September 05, 2018 until and including September 07, 2018 amounts to 98,804 shares. Shares were bought back as follows: Date Number of Shares Average Price Purchased Volume acquired (EUR) (EUR) 03- September -2018 04- September -2018 05- September 32,713 33.0445 1,080,984.73 -2018 06- September 33,076 32.6818 1,080,983.22 -2018 07- September 33,015 32.7422 1,080,983.73 -2018 Total 98,804 32.8221 3,242,951.68 The underlying individual trades are published on the website of QIAGEN N.V. (http://corporate.qiagen.com/investor-relations/share-information/ share-buyback). The total number of shares which have already been bought back within the framework of such tranche of the share repurchase program from September 05, 2018 until and including September 07, 2018 amounts to 98,804 shares. The purchase of the shares of QIAGEN N.V. was carried out by a financial institution that has been commissioned by QIAGEN N.V. Venlo, 11 September 2018 Managing Board ### Contacts: QIAGEN Investor Relations Public Relations John Gilardi [phone] Dr. Thomas Theuringer [phone] 11711 11826 e-mail: [e-mail] e-mail: [e-mail] 11.09.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	QIAGEN N.V.
	Hulsterweg 82
	5912 PL Venlo
	Netherlands
Internet:	www.qiagen.com

End of News	DGAP News Service

722405  11.09.2018